AIA
AGN

Avalon Investment & Advisory’s Allergan plc AGN Stock Holding History

Avalon Investment & Advisory’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,151
Closed -$381K – 351
2020
Q1 		$381K Buy
2,151
+716
+50% +$135K 0.01% 268
2019
Q4 		$274K Buy
1,435
+172
+14% +$31K 0.01% 299
2019
Q3 		$213K Buy
+1,263
New +$206K ﹤0.01% 296
2018
Q1 		– Sell
-45,342
Closed -$7.42M – 378
2017
Q4 		$7.42M Sell
45,342
-8,182
-15% -$1.47M 0.23% 135
2017
Q3 		$11M Sell
53,524
-1,002
-2% -$233K 0.35% 100
2017
Q2 		$13.3M Sell
54,526
-544
-1% -$128K 0.44% 83
2017
Q1 		$13.2M Buy
55,070
+23,751
+76% +$5.53M 0.45% 76
2016
Q4 		$6.58M Sell
31,319
-1,636
-5% -$339K 0.24% 117
2016
Q3 		$7.59M Sell
32,955
-721
-2% -$176K 0.29% 109
2016
Q2 		$7.78M Sell
33,676
-37,807
-53% -$8.72M 0.3% 100
2016
Q1 		$19.2M Sell
71,483
-971
-1% -$278K 0.83% 41
2015
Q4 		$22.6M Sell
72,454
-5,175
-7% -$1.54M 0.98% 32
2015
Q3 		$21.1M Buy
77,629
+2,908
+4% +$893K 0.93% 35
2015
Q2 		$22.7M Buy
74,721
+2,376
+3% +$709K 0.98% 32
2015
Q1 		$21.5M Buy
72,345
+4,077
+6% +$1.16M 0.94% 33
2014
Q4 		$17.6M Buy
68,268
+7,804
+13% +$1.95M 0.8% 43
2014
Q3 		$14.6M Buy
60,464
+1,684
+3% +$377K 0.74% 42
2014
Q2 		$13.1M Buy
58,780
+1,975
+3% +$409K 0.66% 49
2014
Q1 		$11.7M Sell
56,805
-1,145
-2% -$227K 0.65% 60
2013
Q4 		$9.74M Buy
57,950
+715
+1% +$112K 0.54% 75
2013
Q3 		$8.24M Sell
57,235
-5,587
-9% -$744K 0.53% 79
2013
Q2 		$7.93M Buy
+62,822
New +$7.11M 0.47% 90

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Avalon Investment & Advisory's AGN Position: Q2 2020 in Review

Avalon Investment & Advisory sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,151 shares — an estimated $381K sold.

Avalon Investment & Advisory first reported a position in AGN in Q2 2013 and held it in 22 quarters. The position peaked at $22.7M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Avalon Investment & Advisory reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Avalon Investment & Advisory sold 2,151 Allergan plc shares in Q2 2020, an estimated $381K.
  • Avalon Investment & Advisory first reported a position in Allergan plc in Q2 2013 and held it in 22 quarters.
  • Avalon Investment & Advisory's Allergan plc position peaked at $22.7M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Avalon Investment & Advisory's 13F filing for Q2 2020, filed 7 Aug 2020.